Your session is about to expire
← Back to Search
Silica Nanoparticles for Head and Neck Cancer Imaging
Study Summary
This trial is testing if injecting a dye-labeled particle can help visualize cancerous lymph nodes in head and neck cancer patients. This is to improve upon the current standard of care scans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I do not have severe health issues that would prevent me from taking the treatment.My melanoma diagnosis was confirmed through tissue examination at MSKCC.I was recently diagnosed and had a lump removed for testing.My heart is healthy according to my doctor's evaluation.Your white blood cell count and platelet count are high enough as decided by the surgeon.Your bilirubin level should be lower than 2.0 mg/dl, unless your doctor thinks it's okay due to a condition called Gilbert's disease.Women who have not gone through menopause need to have a negative blood pregnancy test.I still have visible tumor signs after initial treatment.I need flap reconstruction in my head or neck after previous cancer treatments.I have been diagnosed with melanoma or squamous cell carcinoma and need SLN mapping.
- Group 1: Phase 2 - Head and Neck Cancer
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are contributing to this research experiment?
"Affirmative. According to the data hosted on clinicaltrials.gov, this research endeavour is actively recruiting participants. It was originally put up for public viewing on April 3rd 2014 and last modified on November 23rd 2022; it requires 86 individuals from two separate sites."
Is this research endeavor currently seeking participants?
"According to clinicaltrials.gov, this medical trial is accepting participants. First posted on April 3rd 2014 and last edited November 23rd 2022, potential volunteers are encouraged to apply."
Share this study with friends
Copy Link
Messenger